http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12538139

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase II|Journal Article
endingPage 4
issn 0250-7005
issueIdentifier 4
pageRange 2361-4
publicationName Anticancer research
startingPage 2361
bibliographicCitation Tomao S, Romiti A, Massidda B, Ionta MT, Farris A, Zullo A, Brescia A, Santuari L, Frati L. A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer. Anticancer Res. 2002 Jul;22(4):2361–4. PMID: 12174927.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c01da0cf837f4959ae4c7760a7a2262c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9051c24cba2ab4fa6cc2a37f0134be99
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8097e567fc3fa904ba7e5f2f5345ed3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef7fd1d5b6c3e489e68f8f4e0a69b624
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ac2e3bf04e91064b67ea607e0dbe451d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f408c958bab3b441479dc3daf9a0aa31
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5309a5bd4054afb08920ed81f00b67bd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a5224fff8321977f178e73bd8a0e4897
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13a059f9616410cb9184b1bab7fede29
date 200207
identifier https://pubmed.ncbi.nlm.nih.gov/12174927
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/592
https://portal.issn.org/resource/ISSN/0250-7005
language English
source https://pubmed.ncbi.nlm.nih.gov/
title A phase II study of gemcitabine and tamoxifen in advanced pancreatic cancer
discusses http://id.nlm.nih.gov/mesh/M0021024
http://id.nlm.nih.gov/mesh/M0028300
http://id.nlm.nih.gov/mesh/M0001471
http://id.nlm.nih.gov/mesh/M0005997
http://id.nlm.nih.gov/mesh/M000754277
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D010190Q000188
http://id.nlm.nih.gov/mesh/D003841Q000031
http://id.nlm.nih.gov/mesh/D000971Q000627
http://id.nlm.nih.gov/mesh/D003841Q000009
http://id.nlm.nih.gov/mesh/D013629Q000009
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000093542
http://id.nlm.nih.gov/mesh/D000964Q000009
http://id.nlm.nih.gov/mesh/D000964Q000008
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D010190Q000473
http://id.nlm.nih.gov/mesh/D018931Q000009
http://id.nlm.nih.gov/mesh/D013921Q000139
http://id.nlm.nih.gov/mesh/D009325Q000139
http://id.nlm.nih.gov/mesh/D009503Q000139
http://id.nlm.nih.gov/mesh/D018931Q000008
http://id.nlm.nih.gov/mesh/D000740Q000139
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D000971Q000009
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D009367
http://id.nlm.nih.gov/mesh/D014839Q000139
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D000368
http://id.nlm.nih.gov/mesh/D013629Q000008
http://id.nlm.nih.gov/mesh/D003841Q000008
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8756
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8766
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53789476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID53787881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID475720827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128713593

Total number of triples: 69.